NCT05379400

Brief Summary

This pilot project is a randomized, double-blind, sham-controlled trial investigating whether in-home air pollution reductions using portable air cleaners (PACs) can decrease circulating concentrations of biomarkers of inflammation. Using both a targeted approach to study the established biomarker TNFa and an exploratory approach with a commercially available proteomic panel, the researchers will measure concentrations of biomarkers before and after four weeks of home PAC use in a cohort of 74 adults with hypertension recruited from NYU outpatient clinical settings. Participants will also track home blood pressure measurements for additional exploratory analysis of potential mediation of PAC-associated decreases in blood pressure by biomarker concentration changes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 18, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

August 11, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 24, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 24, 2023

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

December 6, 2024

Completed
Last Updated

December 6, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

May 12, 2022

Results QC Date

July 26, 2024

Last Update Submit

October 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percent Change in Circulating Concentration of Tumor Necrosis Factor Alpha (TNFα)

    Circulating concentrations of TNFα will be measured using the Olink Explore 384 Cardiometabolic panel for this a priori specified analysis.

    Baseline, Week 4

Secondary Outcomes (1)

  • Change in Indoor Particulate Matter < 2.5 um in Diameter (PM2.5) Concentration

    Baseline, Week 4

Study Arms (2)

Portable Air Cleaner (PAC) group

EXPERIMENTAL

This study will utilize a portable air cleaner as an intervention for the potential reduction of air pollution-associated inflammation. This commercially available device has no significant risks. The researchers plan to use a commercially available PAC with a "true HEPA" filter for the true arm.

Other: Portable air cleaner (PAC)

Sham Portable Air Cleaner (PAC) group

SHAM COMPARATOR

For the sham arm, the same model will be used with HEPA filter removed, and has identical appearance and sound. The researchers will use a PAC designed to filter air in rooms up to approximately 350 ft2, with minimal noise on the lowest setting.

Other: Sham Portable air cleaner (PAC)

Interventions

Commercially available Portable air cleaners (PAC) contain carbon filters that reduce volatile organic carbons and can reduce odors. Because of this, the researchers will remove the carbon filters from all air purifiers to preserve blinding. This will be done by unblinded research staff and devices will be labelled with an ID number to preserve blinding of the rest of the research team.

Portable Air Cleaner (PAC) group

Sham Portable air cleaner (PAC) are commercially available portable air cleaners with the carbon filters and the HEPA filters removed. This will be done by unblinded research staff and devices will be labelled with an ID number to preserve blinding of the rest of the research team.

Sham Portable Air Cleaner (PAC) group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is ≥18 years old
  • Participant and members of household are reported to be non-smokers (defined as no household members are currently known to smoke cigarettes or use other tobacco products including e-cigarettes)
  • Participant is to understand/speak English or Spanish
  • Participant can understand study procedures and give informed consent
  • Participant has stable hypertension: no medication changes in prior 30 days, systolic BP \<160 mm Hg and either ≥ 130 mm Hg without antihypertensive medications, or diagnosis of hypertension in medical records
  • Able to measure home blood pressure twice daily
  • Able to participate in video conference for home equipment setup
  • Able to visit clinic for blood draws before and after the study period
  • Do not intend to sleep anywhere outside of primary bedroom for more than 48 consecutive hours or a total of 7 days during the study period.
  • Ability to lift, or access to assistance with lifting, 20 lb to set up PAC in bedroom.

You may not qualify if:

  • Participants who are unable to provide a minimum of at least one blood pressure measurement per day
  • Participants with average home blood pressure monitor readings of a systolic blood pressure (SBP) \>160 mmHg over any 10-day period during the study. This will be considered evidence of uncontrolled hypertension and will require study termination.
  • Participants with known coronary artery disease
  • Participants with known systemic inflammatory conditions (such as rheumatoid arthritis, inflammatory bowel disease, cancer)
  • Participants currently taking any anti-inflammatory medications or medications that target inflammatory cytokines
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Results Point of Contact

Title
Sharine Wittkopp
Organization
NYU Langone Health

Study Officials

  • Jonathan D Newman

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2022

First Posted

May 18, 2022

Study Start

August 11, 2022

Primary Completion

August 24, 2023

Study Completion

August 24, 2023

Last Updated

December 6, 2024

Results First Posted

December 6, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data. Upon reasonable request. Requests should be directed to Jonathan.Newman@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Locations